Brief: Giant Biogene Logs H1 Gross Margin 81.7%
27/08/2025 15:53
Aug 27 (Reuters) - Giant Biogene Holding Co Ltd 2367.HK: H1 GROSS MARGIN 81.7% H1 CAPEX RMB 295.7 MILLION H1 GROSS PROFIT RMB 2,542.3 MILLION H1 EPS RMB 1.13 H1 BASIC EPS RMB 1.14 H1 NET INCOME RMB 1,182.4 MILLION Further company coverage: 2367.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Giant Biogene Holding
See all newsGiant Biogene's profit drops on higher distribution expenses
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan